1. Home
  2. Journal
  3. GHK-CU: copper peptide research
Cosmetic research

GHK-CU and Anti-Ageing Research Explained

A comprehensive research overview of GHK-CU, the naturally occurring copper peptide complex studied for collagen synthesis, skin regeneration, hair follicle biology and cellular repair mechanisms.

Cosmetic researchPublished Updated 8 min read983 words

Research disclaimer For educational purposes only. GHK-CU is supplied strictly for laboratory research use. Not medical advice. Not for human or animal consumption.

What is GHK-CU?

GHK-CU, glycyl-L-histidyl-L-lysine copper, is a naturally occurring tripeptide copper complex first isolated in 1973 by Loren Pickart from human albumin, a plasma protein. The peptide consists of three amino acids (glycine, histidine and lysine) bound to a copper(II) ion. This copper chelation is central to its biological properties and distinguishes it from non-copper-bound GHK peptide.

GHK-CU is found in several biological fluids and tissues including plasma, saliva and urine, with plasma concentrations showing an age-dependent decline, a fact that has made it a subject of particular interest in ageing biology research. In young adults, plasma GHK-CU concentrations are notably higher than in older individuals, a pattern researchers have studied in relation to age-related changes in tissue repair capacity and skin integrity. A 2015 review by Pickart and colleagues puts plasma levels at about 200 ng/mL at age 20, falling to about 80 ng/mL by age 60.

Cambridge Health supplies GHK-CU in 50mg and 100mg vial formats for laboratory research use only.

The chemistry of GHK-CU: why copper matters

The copper component of GHK-CU is not incidental, it is pharmacologically central. Copper is an essential trace element involved in multiple enzymatic systems including superoxide dismutase (antioxidant defence), cytochrome c oxidase (mitochondrial energy production), lysyl oxidase (collagen and elastin crosslinking) and ceruloplasmin (iron metabolism).

GHK acts as a carrier peptide for copper, facilitating its uptake into cells in a bioavailable form. The tripeptide sequence has a high affinity for Cu(II) ions, forming a stable chelate complex. Research has proposed that this copper delivery function is one of the primary mechanisms through which GHK-CU exerts its studied biological effects, particularly in the context of enzymes that require copper as a cofactor.

The GHK peptide and its copper complex are chemically distinct. Copper coordination, salt form and hydration are relevant when interpreting molecular identity and analytical measurements.

Key research areas

Collagen synthesis research

Perhaps the most extensively studied area of GHK-CU research involves its effects on collagen production. Laboratory studies have demonstrated that GHK-CU can upregulate collagen synthesis in fibroblast cultures, with observed effects on both collagen type I and type III expression. Research has also examined its effects on matrix metalloproteinase (MMP) regulation, particularly the balance between collagen-degrading enzymes and their inhibitors (TIMPs), suggesting a role in collagen remodelling as well as production.

Skin biology and wound healing research

GHK-CU has been studied in multiple skin biology contexts. In wound healing models, research has examined effects on keratinocyte migration, fibroblast proliferation, angiogenesis (via VEGF-related pathways) and dermal matrix organisation. The peptide has been studied both in cell culture models and in vivo wound models, with interest in its ability to influence the rate and quality of skin repair processes.

Studies have also examined GHK-CU's antioxidant properties in skin cell models, with research identifying interactions with NF-κB signalling (a key inflammatory mediator) and SOD1/SOD2 (superoxide dismutase) expression in dermal cells.

Hair follicle research

Hair follicle biology represents a growing area of GHK-CU research interest. Studies have examined the peptide's effects on human hair follicle cell cultures, investigating keratinocyte proliferation, follicle size in ex vivo models and the expression of growth factors relevant to follicle biology including KGF (keratinocyte growth factor) and IGF-1. Findings from cell or isolated follicle models do not establish a treatment effect in people.

Gene expression research

A distinctive area of GHK-CU research involves its broad effects on gene expression. Studies using microarray analysis have identified GHK-CU as a modulator of gene expression across a wide range of biological systems, with one analysis identifying over 4,000 genes with altered expression profiles in response to GHK-CU. This broad transcriptional activity has been interpreted by some researchers as evidence of a fundamental regulatory role, though the full implications remain an active area of investigation.

Anti-ageing and cellular biology research

The age-dependent decline of GHK-CU in plasma has motivated research into its potential roles in cellular ageing processes. Studies have examined GHK-CU in the context of proteasome activity (the cellular protein degradation system), mitochondrial function, DNA repair mechanisms and the biology of cellular senescence. These represent broader systemic research interests extending beyond the skin-focused applications more commonly discussed.

Copper peptides also appear in cosmetic skincare. Cambridge Health makes GlowSkin™, a copper peptide face serum that combines GHK-Cu with SNAP-8 and hydrating ingredients.

GHK-CU in peptide blends

GHK-CU forms the primary component (50mg) of both GLOW70 and KLOW80, the research blends available from Cambridge Health. Its combination with BPC 157 (tissue repair, NO system) and TB500 (actin dynamics, cell migration) creates a multi-mechanism research formulation targeting complementary pathways in skin biology, wound healing and cellular regeneration.

Primary research focus and available sizes of GHK-CU, BPC 157 and TB500
PeptidePrimary research focusAvailable sizes
GHK-CUCollagen, skin, hair, gene expression50mg, 100mg × 10 vials
BPC 157GI tract, tendon, NO system5mg, 10mg, 20mg × 10 vials
TB500Actin dynamics, muscle, cardiac5mg, 10mg × 10 vials

How strong is the evidence for GHK-CU?

Much of what is written about GHK-CU traces back to a small group of review papers. The most cited is Pickart, Vasquez-Soltero and Margolina, "GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration", BioMed Research International, 2015. It is a useful source, but it should be read with its limits in mind.

The laboratory findings it summarises point in a consistent direction. At very low concentrations (1 to 10 nanomolar), GHK-CU stimulated both the synthesis and the breakdown of collagen and glycosaminoglycans in cell studies, and it modulated metalloproteinases and their inhibitors TIMP-1 and TIMP-2. Animal work reported faster wound healing and more blood vessel formation in rabbits, and better healing of diabetic and ischaemic wounds in rats. The review gives no numerical values for the animal results.

The review also states that GHK can up and downregulate at least 4,000 human genes. A Connectivity Map analysis, a Broad Institute database approach that matches compounds to gene expression patterns, found 47 DNA repair genes stimulated and 5 suppressed, using a threshold of at least a 50% change. This kind of data generates hypotheses. It does not show that the same effect occurs in a living person.

The human data in the review come from topical cosmetic studies in women, such as a 12 week facial cream study in 71 women with mild to advanced photoageing and a 12 week eye cream study in 41 women. The review reports no p-values for these trials. Its authors are affiliated with Skin Biology, a company that sells GHK-related products, so independent replication matters.

None of this is evidence about laboratory vials in people. Cambridge Health supplies GHK-CU for laboratory research only, and this article is not guidance on human use. For the supplied vials see GHK-Cu research vials, and for the pen format see LumiPen.

References and evidence context

Pickart L, Vasquez-Soltero JM, Margolina A. GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. BioMed Res Int 2015

GHK-Cu and collagen synthesis in fibroblast cultures

Cell-culture findings provide laboratory context; they do not establish clinical benefit for a supplied product.

Frequently asked questions about GHK-CU

Is GHK-CU proven to work?

In cell and animal models GHK-CU has shown effects on collagen, metalloproteinases and wound healing, but the human data are limited to small topical cosmetic studies reviewed by authors linked to a GHK supplier. Laboratory findings do not establish a benefit for any supplied research product. GHK-CU from Cambridge Health is for laboratory research use only.

What does GHK-CU stand for?

GHK stands for glycyl-L-histidyl-L-lysine, the three amino acids forming the tripeptide sequence. CU refers to copper (from the Latin cuprum), the metal ion chelated by the peptide. Together, GHK-CU refers to the copper-complexed form of the GHK tripeptide.

Why does copper matter in GHK-CU?

Copper is an essential cofactor for multiple enzymes involved in collagen crosslinking (lysyl oxidase), antioxidant defence (SOD), and energy metabolism. GHK acts as a carrier to deliver bioavailable copper to cells, which is central to its studied biological effects, particularly in skin and connective tissue research.

How is GHK-CU different from other skin research peptides?

GHK-CU is a naturally occurring copper-carrying tripeptide with broad gene expression modulating effects. Most other cosmetic research peptides (such as Matrixyl/palmitoyl pentapeptide or Argireline/acetyl hexapeptide) are synthetic signal peptides designed to mimic specific extracellular matrix fragments or neurotransmitter-blocking sequences. GHK-CU's copper chelation chemistry gives it a distinct mechanism from these peptide categories.

What formats does Cambridge Health supply GHK-CU in?

Cambridge Health supplies GHK-CU in 50mg and 100mg formats, in packs of 10 vials, for laboratory research use only. It is also available as a component of GLOW70 and KLOW80 blends.

Important information

Research use only. Not a medicine, not a supplement, not approved for human or animal use.

Cambridge Health™ does not provide usage, dosage, reconstitution or administration guidance for any product. Product information on this page is provided for research and educational context only.

  • Supplied strictly for laboratory and analytical research use. Not for human or animal consumption.
  • No medical advice, treatment guidance or personal use recommendations are provided.
  • Buyers are solely responsible for ensuring that the purchase, import, handling and use of research materials is lawful in their jurisdiction.

Supplied for laboratory research use only. Not a licensed medicine and not approved for human or animal use.

Related

Enquire about GHK-CU research supply

Cambridge Health supplies GHK-CU in 50mg and 100mg formats for laboratory research. Submit a research enquiry.

Submit a purchase request Chat on Telegram

Enquire about GHK-CU research supply

Cambridge Health supplies GHK-CU in 50mg and 100mg formats for laboratory research. Submit a research enquiry.

Chat on Telegram